BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 36076515)

  • 1. Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma.
    Chiu CF; Park JM; Chen HH; Mau CZ; Chen PS; Su YH; Chen HA; Liu YR; Hsieh TH; Chiu CC; Hung SW; Kuo CY; Chen YM; Chang CF
    Biomed Pharmacother; 2022 Sep; 153():113520. PubMed ID: 36076515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
    Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
    Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
    Chen L; Wang Z; Xu Q; Liu Y; Chen L; Guo S; Wang H; Zeng K; Liu J; Zeng S; Yu L
    Theranostics; 2020; 10(8):3562-3578. PubMed ID: 32206108
    [No Abstract]   [Full Text] [Related]  

  • 4. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
    Gao J; Wang L; Xu J; Zheng J; Man X; Wu H; Jin J; Wang K; Xiao H; Li S; Li Z
    J Exp Clin Cancer Res; 2013 Nov; 32(1):86. PubMed ID: 24423239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
    Liu Y; Zheng X; Yu Q; Wang H; Tan F; Zhu Q; Yuan L; Jiang H; Yu L; Zeng S
    Sci Transl Med; 2016 Jul; 8(348):348ra97. PubMed ID: 27440728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of
    Zhu Q; Yu L; Qin Z; Chen L; Hu H; Zheng X; Zeng S
    Epigenetics; 2019 Aug; 14(8):791-803. PubMed ID: 31088315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance.
    Wang G; Chen J; Dai S; Zhang J; Gao Y; Yin L; Jiang K; Miao Y; Lu Z
    Apoptosis; 2024 Apr; 29(3-4):344-356. PubMed ID: 37848674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic cation transporter 2 and tumor budding as independent prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy.
    Tatsumi S; Matsuoka H; Hashimoto Y; Hatta K; Maeda K; Kamoshida S
    Int J Clin Exp Pathol; 2014; 7(1):204-12. PubMed ID: 24427340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer.
    Zheng S; Tian Q; Yuan Y; Sun S; Li T; Xia R; He R; Luo Y; Lin Q; Fu Z; Zhou Y; Chen R; Hu C
    J Exp Clin Cancer Res; 2023 Nov; 42(1):324. PubMed ID: 38012734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma.
    Shao F; Huang M; Meng F; Huang Q
    Front Pharmacol; 2018; 9():584. PubMed ID: 29922161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
    Sprowl JA; Ciarimboli G; Lancaster CS; Giovinazzo H; Gibson AA; Du G; Janke LJ; Cavaletti G; Shields AF; Sparreboom A
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11199-204. PubMed ID: 23776246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing GnT-V reduces oxaliplatin chemosensitivity in human colorectal cancer cells through N-glycan alteration of organic cation transporter member 2.
    Cong X; Liu X; Dong X; Fang S; Sun Z; Fan J
    Exp Ther Med; 2021 Feb; 21(2):128. PubMed ID: 33376510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors.
    Visentin M; Torozi A; Gai Z; Häusler S; Li C; Hiller C; Schraml PH; Moch H; Kullak-Ublick GA
    Drug Metab Dispos; 2018 Aug; 46(8):1129-1136. PubMed ID: 29794161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapy.
    Tashiro A; Tatsumi S; Takeda R; Naka A; Matsuoka H; Hashimoto Y; Hatta K; Maeda K; Kamoshida S
    Am J Cancer Res; 2014; 4(5):528-36. PubMed ID: 25232494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
    Burger H; Zoumaro-Djayoon A; Boersma AW; Helleman J; Berns EM; Mathijssen RH; Loos WJ; Wiemer EA
    Br J Pharmacol; 2010 Feb; 159(4):898-908. PubMed ID: 20067471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.
    Huang KM; Leblanc AF; Uddin ME; Kim JY; Chen M; Eisenmann ED; Gibson AA; Li Y; Hong KW; DiGiacomo D; Xia SH; Alberti P; Chiorazzi A; Housley SN; Cope TC; Sprowl JA; Wang J; Loprinzi CL; Noonan A; Lustberg MB; Cavaletti G; Pabla N; Hu S; Sparreboom A
    J Clin Invest; 2020 Sep; 130(9):4601-4606. PubMed ID: 32484793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.
    Ding Y; Mei W; Zheng Z; Cao F; Liang K; Jia Y; Wang Y; Liu D; Li J; Li F
    Tissue Cell; 2021 Dec; 73():101623. PubMed ID: 34543801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
    Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
    Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.